RenovoRx (RNXT) Operating Leases (2024 - 2026)
RenovoRx's (RNXT) quarterly Operating Leases came in at $390000.0 in Q2 2026, up 142.24% year-over-year from $161000.0 in Q2 2025, and up 109.68% quarter-over-quarter from $186000.0 in Q1 2026.
Analysis
RenovoRx (RNXT) Operating Leases (2024 - 2026) Analysis & Trends
RenovoRx has disclosed Operating Leases across 3 years of filings, most recently posting $390000.0 for Q2 2026.
- In Q2 2026, Operating Leases rose 142.24% year-over-year to $390000.0; the TTM figure through Jun 2026 stood at $390000.0 (up 142.24% YoY), while the FY2025 annual figure was $212000.0, changed 0.0% from the prior year.
- Operating Leases came in at $390000.0 for Q2 2026 at RenovoRx, up from $186000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $390000.0 in Q2 2026 to a low of $134000.0 in Q3 2025.
- Average Operating Leases over 3 years is $211571.4, with a median of $186000.0 recorded in 2025.
- Year-over-year, Operating Leases changed 0.0% in 2025 and jumped 142.24% in 2026.
- Over 3 years, Operating Leases stood at $212000.0 in 2024, then changed by 0.0% to $212000.0 in 2025, then surged by 83.96% to $390000.0 in 2026.
- Per Business Quant data, the three most recent Operating Leases figures were $390000.0 in Q2 2026, $186000.0 in Q1 2026, and $212000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | RenovoRx | 83.48 Mn | 83.48 Mn | 766,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 390,000.00 |
| Mar 31, 2026 | 186,000.00 |
| Dec 31, 2025 | 212,000.00 |
| Sep 30, 2025 | 134,000.00 |
| Jun 30, 2025 | 161,000.00 |
| Mar 31, 2025 | 186,000.00 |
| Dec 31, 2024 | 212,000.00 |